Announcement on Convening Semi-annual Performance Briefing 2024
Filed with SSE · · 2 pages · Chinese
Zhejiang Ausun Pharmaceutical Co., Ltd. on 6ix
Later from Zhejiang Ausun Pharmaceutical
- Report for Q3 2024
- Announcement on Wholly-owned Subsidiary Obtaining "Drug Registration Certificate" for Sitafloxacin Tablets
- Announcement on Returning the Raised Funds Used for Temporarily Supplementing the Working Capital
- Announcement onUsing Some Idle Raised Funds to Temporarily Supplement Current Capital
- Announcement on Obtaining Overseas Marketing Authorization for Cooperative Product Imatinib Mesylate Tablets
Follow Zhejiang Ausun Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Ausun Pharmaceutical